Holen Sie sich die Stockscreener-App
0.4066
2.73%
-0.0114
Handel nachbörslich:
.42
0.0134
+3.30%
Schlusskurs vom Vortag:
$0.418
Offen:
$0.4077
24-Stunden-Volumen:
345.33K
Relative Volume:
0.01
Marktkapitalisierung:
$24.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.26M
KGV:
-0.3442
EPS:
-1.1814
Netto-Cashflow:
$-13.50M
1W Leistung:
-3.17%
1M Leistung:
-3.47%
6M Leistung:
+35.53%
1J Leistung:
-78.89%
1-Tages-Spanne:
$0.4011
$0.4172
1-Wochen-Bereich:
$0.3672
$0.433
52-Wochen-Spanne:
$0.1853
$3.1663
Intensity Therapeutics Inc Stock (INTS) Company Profile
Firmenname
Intensity Therapeutics Inc
Sektor
Branche
Telefon
203-221-7381
Adresse
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Vergleichen Sie INTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.4066 | 25.11M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.99 | 116.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.71 | 82.52B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.69 | 52.67B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
849.95 | 52.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.42 | 37.70B | 447.02M | -1.18B | -906.14M | -6.1812 |
Intensity Therapeutics Inc Aktie (INTS) Neueste Nachrichten
Why Intensity Therapeutics Inc. stock appeals to analystsJuly 2025 Sentiment & Daily Profit Maximizing Tips - Улправда
Why Intensity Therapeutics Inc. stock is a must watch in 2025July 2025 Analyst Calls & Weekly High Conviction Ideas - Улправда
Why Intensity Therapeutics Inc. stock is rated strong buyWeekly Stock Summary & AI Enhanced Trade Execution Alerts - DonanımHaber
Can Intensity Therapeutics Inc. stock double in next 5 years2025 Fundamental Recap & Weekly Breakout Watchlists - Улправда
CEO Change: Can Intensity Therapeutics Inc. stock attract ESG capital inflows2025 Risk Factors & Precise Buy Zone Identification - moha.gov.vn
How Intensity Therapeutics Inc. stock performs in high volatility marketsJuly 2025 Big Picture & Real-Time Stock Entry Alerts - Улправда
Can Intensity Therapeutics Inc. stock rebound after recent weaknessWeekly Volume Report & Risk Managed Investment Signals - DonanımHaber
Portfolio Shifts: Will Intensity Therapeutics Inc. stock split attract more investorsPortfolio Return Report & Real-Time Buy Signal Notifications - Улправда
Will Intensity Therapeutics Inc. stock split attract more investorsJuly 2025 News Drivers & AI Based Buy and Sell Signals - Улправда
Growth Review: What insider trading reveals about Intensity Therapeutics Inc. stockJuly 2025 Sector Moves & AI Based Trade Execution Alerts - DonanımHaber
Fundamentals Check: Can Intensity Therapeutics Inc. stock double in next 5 yearsWeekly Gains Report & Growth Focused Entry Reports - Улправда
Can Intensity Therapeutics Inc. stock resist sector downturns2025 Earnings Impact & Fast Gain Stock Tips - Улправда
Is Intensity Therapeutics Inc. stock supported by innovation pipelineDip Buying & Daily Volume Surge Trade Alerts - Улправда
Market Review: Why Intensity Therapeutics Inc. stock is a must watch in 2025IPO Watch & Verified Technical Signals - Улправда
MSN Money - MSN
Intensity Therapeutics to present two posters ay SABCS - MSN
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy - sharewise.com
All you need to know about Intensity Therapeutics Inc. (INTS) rating upgrade to buy - MSN
Immuron (IMRN) struggles after announcing trial results - MSN
Value Recap: Is Intensity Therapeutics Inc stock positioned for digital transformationJuly 2025 Snapshot & Technical Confirmation Trade Alerts - moha.gov.vn
Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium - PR Newswire
What drives Intensity Therapeutics Inc stock priceTechnology Stock Trends & Explosive Profit Potential - earlytimes.in
Intensity Therapeutics reports Q3 EPS (6c) vs. (25c) last year - MSN
You might want to take a look at Intensity Therapeutics Inc (INTS) now - setenews.com
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement - marketscreener.com
HC Wainwright & Co. initiates coverage of Pasithea Therapeutics (KTTA) with buy recommendation - MSN
Intensity Therapeutics granted 180-day extension to regain Nasdaq compliance - MSN
INTS Stock Price and Chart — NASDAQ:INTS - TradingView
Update Report: How Intensity Therapeutics Inc stock benefits from global expansionPortfolio Gains Summary & AI Based Trade Execution Alerts - moha.gov.vn
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule - Investing.com Nigeria
Intensity Therapeutics receives 180-day Nasdaq extension to regain compliance - MSN
Intensity Therapeutics stock rises after securing Nasdaq listing extension By Investing.com - Investing.com Nigeria
Intensity Therapeutics stock rises after securing Nasdaq listing extension - Investing.com
Intensity Therapeutics Gets Extension to Regain Nasdaq Minimum Price Requirement - marketscreener.com
Intensity Therapeutics Granted Nasdaq Compliance Extension - TipRanks
Intensity Therapeutics granted 180-day extension - marketscreener.com
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule By Investing.com - Investing.com South Africa
Intensity Therapeutics jumps after Nasdaq grants compliance extension - TradingView — Track All Markets
Intensity Therapeutics, Inc. (INTS) 18.98% in Intraday Trading: Surge Ahead of Conference Presentations - Stocks Telegraph
Intensity Therapeutics expands at-the-market offering - MSN
Intensity Therapeutics files for offering of up to $30 million common stockSEC filing - marketscreener.com
Intensity Therapeutics expands at-the-market offering program to $30 million - Investing.com Australia
Intensity Therapeutics announces two presentations at the upcoming 2025 San Antonio Breast Cancer Symposium - marketscreener.com
Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium - Nasdaq
Intensity Therapeutics expands at-the-market offering program to $30 million By Investing.com - Investing.com South Africa
Intensity Therapeutics Expands At-The-Market Offering - TipRanks
Intensity Therapeutics Expands ATM Offering to $30 Million - TradingView — Track All Markets
Chipmakers Recap: Why FARO Technologies Inc. stock could see breakout soonWall Street Watch & Momentum Based Trading Signals - BỘ NỘI VỤ
How Intensity Therapeutics Inc. stock benefits from global expansionEarnings Recap Report & Verified Chart Pattern Signals - Newser
Delving into the physics of cancer, with Lew Bender - pharmaphorum
Intensity Therapeutics (INTS) Stock Analysis Report | Financials & Insights - Benzinga
Finanzdaten der Intensity Therapeutics Inc-Aktie (INTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):